Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Psoriatic arthritis

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials

Online download statistics by month:

Online download statistics by month: October 2020 to December 2022

	Abstract	Full	Pdf
Oct 2020	726	718	308
Nov 2020	1083	1069	704
Dec 2020	850	845	439
Jan 2021	1456	1437	430
Feb 2021	545	532	257
Mar 2021	386	376	289
Apr 2021	289	281	171
May 2021	252	238	134
Jun 2021	217	211	101
Jul 2021	237	232	150
Aug 2021	241	236	157
Sep 2021	254	248	122
Oct 2021	307	299	144
Nov 2021	393	388	130
Dec 2021	286	284	74
Jan 2022	281	285	97
Feb 2022	192	186	102
Mar 2022	274	272	96
Apr 2022	294	289	89
May 2022	200	205	128
Jun 2022	198	198	109
Jul 2022	176	181	110
Aug 2022	202	196	76
Sep 2022	211	210	121
Oct 2022	189	181	85
Nov 2022	203	199	78
Dec 2022	145	140	59
Total	10087	9936	4760